ResMed’s strong demand for AirSense 11 boosts its earnings outlook. Learn why RMD stock is undervalued with growth ...

ResMed reported robust earnings for the second quarter of fiscal 2025, surpassing expectations and showcasing strong growth ...

Q2 2025 Earnings Call Transcript January 30, 2025 ResMed Inc. beats earnings expectations. Reported EPS is $2.43, expectations were $2.32. Operator: Welcome to the Q2 Fiscal Year 2025 ResMed Earnings ...

Resmed has its origins in the 1980s, when Sydney sleep expert Dr Colin Sullivan converted a vacuum cleaner to deal with the ...

During the quarter, we launched the AirTouch N30i to select markets. The AirTouch N30i is a world first from ResMed with its unique fabric-based patient interface. My philosophy is this. We sleep on ...

Mr Farrell said the company’s future growth would build on its strong research and development base, with the launch of the fabric mask AirTouch N30i, a world-class innovation. He also said the ...

The quarter saw ResMed continue its strategic expansion with significant investments in innovation, including the launch of new products like the AirTouch N30i mask, designed to enhance patient ...

At a more micro-level, RMD has invested heavily in its new fabric-based AirTouch N30i mask, and I’m sure that the company and the market is baking in some upside from this innovation.

Mobilized Verizon Wireless managed by Kim Berry is your local solution for all your cell phone needs. They offer a wide ...

ResMed (ASX: RMD) posted a solid December quarter, with most figures slightly exceeding market expectations, driven by strong device growth.